Platelet-Rich Plasma in the Treatment of Alopecia Areata After COVID-19 Vaccination

    May 2023 in “ Clinical case reports ”
    Hsiang‐Chiun Teng, H. Chen
    Studysummary In this case report, a 34-year-old woman developed severe alopecia areata after her second COVID-19 vaccination, but her hair fully recovered following six platelet-rich plasma treatments, highlighting PRP as a potential alternative for patients who cannot tolerate or do not respond to corticosteroids.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Therapeutic Options To Refractory Alopecia Areata International journal of medical science and clinical research studies · 2023
    2. New Insights into Alopecia Areata During COVID-19 Pandemic: When Infection or Vaccination Could Play a Role Journal of Cosmetic Dermatology · 2022
    3. Frontiers in Alopecia Areata Pathobiology Research ˆThe ‰journal of allergy and clinical immunology/Journal of allergy and clinical immunology/˜The œjournal of allergy and clinical immunology · 2019
    4. Alopecia Areata: An Update Indian Journal of Dermatology, Venereology and Leprology · 2013
    5. Trichohyalin Is a Potential Major Autoantigen in Human Alopecia Areata Journal of Proteome Research · 2010
    6. Hair Loss After Routine Immunizations JAMA · 1997

    Related research 2

    1. Serum Zinc Concentration in Patients With Alopecia Areata Acta dermato-venereologica (Print) · 2023
    2. Platelet-Rich Plasma (PRP) as a New Approach and Promising Therapy in Patients With Alopecia Areata Medica Hospitalia: Journal of Clinical Medicine · 2023